Adjuvant Osimertinib for EGFR-Mutated Lung Cancer: Maximizing Disease-Free Survival
Surgery removes the visible lung tumor. However, microscopic cancer cells often remain hidden in the body. These unseen cells can cause the cancer to return. The fear of recurrence is a heavy burden after a successful operation. Adjuvant therapy with Osimertinib targets these hidden cells. It significantly improves disease-free survival for patients with specific genetic …
